WHO H1N1 vaccine shipments headed to more developing countries

NewsGuard 100/100 Score

The WHO on Friday announced "it had delivered the first doses of H1N1 [swine flu] vaccine to Cuba, and a dozen countries in Africa would receive millions of doses in coming weeks," Reuters reports. According to WHO spokeswoman Karen Mah, Cuba received an estimated 1.1 million doses Wednesday, and Honduras and El Salvador shipments are "en route," according to the news service.

According to Reuters, "Cuba has reported 54 deaths from H1N1 flu, also known as swine flu, the greatest number in the Caribbean, according to the U.N. agency. … The H1N1 virus also continues to spread across much of West Africa, including in Ghana and Nigeria, although clinical data is limited, the WHO said" (Nebehay, 3/19).

WHO spokesman Gregory Hart said, 10-15 countries in Africa, including Kenya, Nigeria and South Africa, will receive H1N1 vaccines within weeks, Reuters writes in a second story. "The shipment for Nigeria, expected to go in coming days, would contain about 2.8 million doses," the news service writes (3/19).

Xinhua reports Hartl also named Cameroon, Togo and Namibia to be recipients of H1N1 vaccines from the WHO (3/20).

The WHO "says so far, it has delivered more than four million doses of the H1N1 swine flu vaccine to 17 countries," VOA News reports in a story that examines the criteria countries must meet before becoming eligible to receive the H1N1 vaccines. "The stocks are among 180 million doses of the vaccine donated to the WHO from pharmaceutical companies and industrialized countries" (Schlein, 3/20).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Nigeria first to rollout new Men5CV vaccine against meningitis